ADA example [Bioanalytics]

posted by mittyri  – Russia, 2019-03-18 23:20 (2266 d 03:20 ago) – Posting: # 20047
Views: 6,969

Hi Helmut,

Thank you so much for the detailed answer!

❝ ❝ Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?


❝ Not sure what you mean here.


Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}


Edit: Guidance linked. [Helmut]

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
63 visitors (0 registered, 63 guests [including 15 identified bots]).
Forum time: 03:41 CEST (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5